Hulls Chris 4

Accession 0000905148-25-004189

CIK 0001581760other

View on SEC.gov Company Profile

Filed

Nov 25, 7:00 PM ET

Accepted

Nov 26, 9:56 PM ET

Size

29.5 KB

Accession

0000905148-25-004189

Insider Transaction Report

Form 4

Period: 2025-11-25

Life360, Inc.LIF

Hulls Chris

DirectorChief Executive Officer

Transactions

Exercise/Conversion
Common Stock
2025-11-25$2.15/sh+208,987$449,322→ 685,665 total
Exercise/Conversion
Common Stock
2025-11-25$13.35/sh+95,833$1,279,371→ 781,498 total
Sale
Common Stock
2025-11-25$76.91/sh−226,556$17,424,422→ 554,942 total
Sale
Common Stock
2025-11-25$77.56/sh−80,193$6,219,769→ 474,749 total
Sale
Common Stock
2025-11-25$78.38/sh−5,000$391,900→ 469,749 total
Gift
Common Stock
2025-11-25−62,500→ 407,249 total
Exercise/Conversion
Common Stock
2025-11-26$8.19/sh+48,164$394,463→ 455,413 total
Sale
Common Stock
2025-11-26$78.62/sh−100,465$7,898,558→ 354,948 total
Sale
Common Stock
2025-11-26$79.11/sh−19,535$1,545,414→ 335,413 total
Exercise/Conversion
Stock Option (right to buy)
2025-11-25−208,987→ 0 total
Exercise: $2.15Exp: 2027-10-24→ Common Stock (208,987 underlying)
Exercise/Conversion
Stock Option (right to buy)
2025-11-25−95,833→ 4,167 total
Exercise: $13.35Exp: 2027-02-01→ Common Stock (95,833 underlying)
Exercise/Conversion
Stock Option (right to buy)
2025-11-26−48,164→ 233,801 total
Exercise: $8.19Exp: 2028-05-20→ Common Stock (48,164 underlying)

Holdings

Common Stock
(indirect: By Trust)
195,312
Common Stock
(indirect: By LLC)
1,846

Footnotes (12)

[F1]Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.
[F10]The Reporting Person is a member of ICCA Labs, LLC, an entity that holds an aggregate of 8,219 shares of the Issuer's common stock. The number of shares held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC.
[F11]The stock option is fully vested and exercisable.
[F12]The stock option vests and becomes exercisable as to 1/48th of the total number of shares in equal monthly installments beginning on February 1, 2022, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
[F2]Includes 137,853 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
[F3]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $76.25 to $77.245, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
[F4]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $77.25 to $78.21, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
[F5]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $78.32 to $78.43, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
[F6]This transaction reflects a bona fide gift of the Issuer's stock to a donor-advised fund (DAF) for charitable purposes. The Reporting Person retains no beneficial ownership or control over the donated securities following the contribution.
[F7]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $78.02 to $79.015, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
[F8]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $79.02 to $79.34, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
[F9]Represents shares of the Issuer's common stock underlying 585,938 CDIs.

Documents

1 file

4
form4.xmlPrimary

Issuer

Life360, Inc.

CIK 0001581760

→

Entity typeother

Related Parties

filerCIK 0001932498

Filing Metadata

Form type: 4
Filed: Nov 25, 7:00 PM ET
Accepted: Nov 26, 9:56 PM ET
Size: 29.5 KB

View on SEC.gov